David James (cell biologist)

Last updated

David Ernest James FAA (born in Sydney in 1958) is a cell biologist who discovered the glucose transporter GLUT4. He has also been responsible for the molecular dissection of the intracellular trafficking pathways that regulate GLUT4 translocation to the cell surface, the topological mapping of the insulin signal transduction pathway, the creation of a method for studying in vivo metabolism in small animals, and the use of this method to gain insights into whole-animal fuel metabolism and homeostasis.

Contents

Career

In 1979 he graduated with a BSc (Hons) from the University of New South Wales, and gained his Ph.D. at the Garvan Institute of Medical Research in 1985. [1] Subsequently he pursued postdoc research at Boston University and Washington University in St. Louis in the USA. In 1993 he returned to Australia, first to Brisbane and then once again at the Garvan Institute. In 2014 he moved to the University of Sydney. [2]

He currently holds joint appointments as the Leonard P Ullmann Chair in Molecular Systems Biology and as the Domain Leader for Biology at the Charles Perkins Centre at The University of Sydney. [2] [3]

Awards and honours

See also

Related Research Articles

<span class="mw-page-title-main">WEHI</span> Medical research institute in Victoria, Australia

WEHI, previously known as the Walter and Eliza Hall Institute of Medical Research, and as the Walter and Eliza Hall Institute, is Australia's oldest medical research institute. Sir Frank Macfarlane Burnet, who won the Nobel Prize in 1960 for his work in immunology, was director from 1944 to 1965. Burnet developed the ideas of clonal selection and acquired immune tolerance. Later, Professor Donald Metcalf discovered and characterised colony-stimulating factors. As of 2015, the institute hosted more than 750 researchers who work to understand, prevent and treat diseases including blood, breast and ovarian cancers; inflammatory diseases (autoimmunity) such as rheumatoid arthritis, type 1 diabetes and coeliac disease; and infectious diseases such as malaria, HIV and hepatitis B and C.

<span class="mw-page-title-main">John Shine</span> Australian biochemist and molecular biologist

John Shine is an Australian biochemist and molecular biologist. Shine and Lynn Dalgarno discovered a nucleotide sequence, called the Shine-Dalgarno sequence, necessary for the initiation of protein synthesis. He directed the Garvan Institute of Medical Research in Sydney from 1990 to 2011. From 2018 to 2022, Shine was President of the Australian Academy of Science.

<span class="mw-page-title-main">Randy Schekman</span> American cell biologist

Randy Wayne Schekman is an American cell biologist at the University of California, Berkeley, former editor-in-chief of Proceedings of the National Academy of Sciences and former editor of Annual Review of Cell and Developmental Biology. In 2011, he was announced as the editor of eLife, a new high-profile open-access journal published by the Howard Hughes Medical Institute, the Max Planck Society and the Wellcome Trust launching in 2012. He was elected to the National Academy of Sciences in 1992. Schekman shared the 2013 Nobel Prize for Physiology or Medicine with James Rothman and Thomas C. Südhof for their ground-breaking work on cell membrane vesicle trafficking.

The Kolling Institute is located in the grounds of the Royal North Shore Hospital in St Leonards, Sydney Australia. The institute, founded in 1920, is the oldest medical research institute in New South Wales.

<span class="mw-page-title-main">Cambridge Biomedical Campus</span> Science park in Cambridge, UK

The Cambridge Biomedical Campus is the largest centre of medical research and health science in Europe. The site is located at the southern end of Hills Road in Cambridge, England.

<span class="mw-page-title-main">Garvan Institute of Medical Research</span>

The Garvan Institute of Medical Research is an Australian biomedical research institute located in Darlinghurst, Sydney, New South Wales. Founded in 1963 by the Sisters of Charity as a research department of St Vincent's Hospital, it is now one of Australia's largest medical research institutions, with approximately 750 scientists, students and support staff.

Marshall (Hal) Davidson Hatch AM (born 24 December 1932) was an Australian biochemist and plant physiologist. He was the chief research scientist at the CSIRO Division of Plant Industry in Canberra. He is a Fellow of the Australian Academy of Science, a Fellow of the Royal Society, a Foreign Associate of the US National Academy of Sciences and was awarded Honorary Doctorates from the University of Göttingen and the University of Queensland. In Australia, in 1966, he elucidated, jointly with Charles Roger Slack, the C4 pathway for the fixation of carbon, which is also sometimes known as the Hatch-Slack pathway. He is now retired.

<span class="mw-page-title-main">Harvey Lodish</span> American cell biologist, born 1941

Harvey Franklin Lodish is a molecular and cell biologist, professor at the Massachusetts Institute of Technology (MIT), Founding Member of the Whitehead Institute for Biomedical Research, and lead author of the textbook Molecular Cell Biology. Lodish's research focused on cell surface proteins and other important areas at the interface between molecular cell biology and medicine.

Utpal Banerjee is a distinguished professor of the department of molecular, cell and developmental biology at UCLA. He obtained his Bachelor of Science degree in chemistry from St. Stephen's College, Delhi University, India and obtained his Master of Science degree in physical chemistry from the Indian Institute of Technology, Kanpur, India. In 1984, he obtained a PhD in chemistry from the California Institute of Technology where he was also a postdoctoral Fellow in the laboratory of Seymour Benzer from 1984-1988.

The School of Biological Sciences is a research-led academic community at the University of East Anglia. It works with partners in industry on a range of activities, including translating research discoveries into products, making knowledge and research expertise available through consultancies, contract research and provision of analytical services, as well as partnering industry in training both undergraduate and postgraduate students.

<span class="mw-page-title-main">John Mattick</span> Australian molecular biologist (born 1950)

John Stanley Mattick is an Australian molecular biologist known for his efforts to assign function to non-coding DNA. Mattick was the executive director of the Garvan Institute of Medical Research from 2012 to 2018. He joined Genomics England in May 2018 as chief executive officer. In October 2019, he joined the University of New South Wales in Sydney.

Russell J. Howard is an Australian-born executive, entrepreneur and scientist. He was a pioneer in the fields of molecular parasitology, especially malaria, and in leading the commercialisation of one of the most important methods used widely today in molecular biology today called “DNA shuffling" or "Molecular breeding", a form of "Directed evolution".

<span class="mw-page-title-main">Matthias Tschöp</span> German neuroendocrinologist (born 1967)

Matthias H. Tschöp is a German physician and scientist. He is the chief executive officer and scientific director of Helmholtz Zentrum München, German Research Center for Environmental Health. He is also Alexander von Humboldt Professor and chair of metabolic diseases at Technical University of Munich and serves as an adjunct professor at Yale University.

<span class="mw-page-title-main">Stephen Simpson (professor)</span> Australian scientist

Stephen James Simpson is the executive director of Obesity Australia and the academic director of the Charles Perkins Centre.

Barbara B. Kahn is an endocrinologist and the George Richards Minot professor of medicine at Harvard Medical School. She is also the vice chair for research strategy in the department of medicine at Beth Israel Deaconess Medical Center, and was formerly the chief of the Division of Endocrinology, Diabetes, and Metabolism at Beth Israel Deaconess. Her research focuses on insulin resistance and type 2 diabetes.

<span class="mw-page-title-main">Antonio Vidal-Puig</span> Spanish medical doctor and scientist

Antonio Vidal-Puig is a Spanish medical doctor and scientist who works as a Professor of Molecular Nutrition and Metabolism at the University of Cambridge (UK), best known for advancing the concept that pharmacological targeting of brown fat may serve to treat overweight and obesity in affected individuals, as well as for introducing the concept of adipose tissue "expandability" as an important factor in the pathogenesis of insulin resistance in the context of positive energy balance. His published work focuses on areas such as adipose tissue metabolism and lipotoxicity, regulation of insulin secretion, and the pathophysiology of metabolic syndrome, obesity, and type 2 diabetes.

Cecilia Margareta Lindgren is a Swedish geneticist. She is a Professor of Genomic Endocrinology & Metabolism in the Nuffield Department of Population Health at the University of Oxford, where she is also Group Head at the Wellcome Centre for Human Genetics and a research fellow at St. Anne's College. She became Director of the Big Data Institute at Oxford on 1 April 2021; she had previously been a Senior Group Leader at the Institute. Lindgren is best known for her research on the genetics of obesity and other complex traits.

<span class="mw-page-title-main">Robert M. Graham (cardiologist)</span> Australian medical researcher

Robert Michael Graham AO, FAA, FAHMS is an Australian-born clinician-scientist. He is the Des Renford Professor of Medicine at University of New South Wales and the Head of the Molecular Cardiology and Biophysics Division at Victor Chang Cardiac Research Institute.

Reuben Shaw is an American cancer researcher. He is a professor and director of the National Cancer Institute-Designated Cancer Center at the Salk Institute for Biological Studies, one of the NCI's seven basic laboratory cancer centers in the United States. He researches signaling pathways that control tumor metabolism, with a specific focus on an ancient energy-sensing pathway that controls biological response to starvation.

Robert G. Parton FAA is a British/Australian cell biologist. He is a Group Leader in the Institute for Molecular Bioscience, University of Queensland and Deputy Director of the University of Queensland Centre for Microscopy and Microanalysis.

References

  1. "Professor David James FAA – Garvan Institute". Old.garvan.org.au. Archived from the original on 8 April 2020. Retrieved 31 March 2014.
  2. 1 2 "Professor David James" . Retrieved 10 July 2020.
  3. "2020 Laureate Profile: Professor David James" . Retrieved 10 July 2020.